share_log

德琪醫藥-B:澄清及按照2022年受限制股份單位計劃實際授出受限制股份單位及根據2022年一般授權發行新股份

ANTENGENE-B: CLARIFICATION AND ACTUAL GRANT OF RSUs AND ISSUE OF NEW SHARES UNDER 2022 GENERAL MANDATE PURSUANT TO THE 2022 RSU SCHEME

Nov 1, 2022 10:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more